Focus
Drug Discovery Investors: Angels and VC Firms
The RaiseHunt database lists 4,683 Drug Discovery investors: 239 angel investors and 4,444 people at 1,313 firms. Most list Seed and Series A among their stages; the largest hubs are New York, San Francisco and Boston.
Strongest in New York, San Francisco and Boston
- 4,683
- Drug Discovery investors
- 239
- Angel investors
- 4,444
- People at VC/PE firms
- 1,313
- Firms tagged
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
4,683 Drug Discovery investors
Showing 181-200
| Investor | Location | Type | Markets | Contact | Actions |
|---|---|---|---|---|---|
 Jeff Goater Partner at The Column Group | Boston, United States | Venture capital | Healthcare | View profile | |
 Veranika Razhkova Principal at Deerfield Management | New York, United States | Private equityVenture capital | AIHealthcare | View profile | |
 Zak Burns Investor at New Enterprise Associates (NEA) | New York City, United States | Venture capital | AICommerce | View profile | |
 Jason Masciarelli VP, Launchpad Go-To-Market & Ventures at Pegasystems | Amherst, United States | Corporate VCGovernment-backed | AIHardware | View profile | |
 Elise Wang Partner at Deerfield Management | New York, United States | Private equityVenture capital | AIHealthcare | View profile | |
 Andrew ElBardissi Partner at Deerfield Management | New York, United States | Private equityVenture capital | AIHealthcare | View profile | |
 Richard Gaster Managing Partner at venBio | San Francisco, United States | Venture capital | Healthcare | View profile | |
 Anthony Arceci Biotech Investor at 5AM Ventures | Boston, United States | Venture capital | Healthcare | View profile | |
 Laia Crespo Partner at Sanofi | Paris, France | Corporate VC | AIHealthcare | View profile | |
 Vincent Mellet Partner at Deerfield Management | New York, United States | Private equityVenture capital | AIHealthcare | View profile | |
 Mario Reto Principal at Ampersand Capital Partners | Boston, United States | Private equity | CommerceHardware | View profile | |
 John Drake Chairman at Recollective | London, Canada | Corporate VC | HealthcareSaaS | View profile | |
 Edmi Vazquez Private Markets Investments at American Chemical Society | Washington, United States | Government-backed | ClimateEducation | View profile | |
 Pau Fernandez Guirao Partner at Itnig | Cabrils, Spain | AcceleratorVenture capital | AIHealthcare | View profile | |
 Victor Rusu Principal at MPM BioImpact | Boston, United States | Private equityVenture capital | Healthcare | View profile | |
 Jason P. Hafler Investor at Sanofi | Cambridge, United States | Corporate VC | AIHealthcare | View profile | |
 Gilan Megeed Principal, Medtech at Deerfield Management | New York, United States | Private equityVenture capital | AIHealthcare | View profile | |
 Jason Rhodes Partner at Atlas Venture | Cambridge, United States | Venture capital | CommerceConsumer | View profile | |
 Maurizio Fazio Principal at Atlas Venture | Cambridge, United States | Venture capital | CommerceConsumer | View profile | |
 Mira Chaurushiya Managing Director at Westlake BioPartners® | San Francisco, United States | AcceleratorSyndicate / Angel group | FinTechHardware | View profile |
Data: RaiseHunt investor dataset · Snapshot 27 August 2026 · How this data is built · Report a correction or request removal